title: Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms.
authors.forename: Karl
authors.initials: K
authors.lastname: Haslam
authors.forename: Karen M
authors.initials: KM
authors.lastname: Molloy
authors.forename: Eibhlin
authors.initials: E
authors.lastname: Conneally
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Langabeer
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology / Q000601:surgery*; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000235:genetics; D016133:Polymerase Chain Reaction; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D053614:Janus Kinase 2